Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches

<div>Flow diagram for preferred add-on medications according to the included studies in the systematic review. <sup>1</sup>Saxagliptin is not yet recommended. <sup>2</sup>GLP1RA’s such as exenatide, liraglutide, and beinaglutide. <sup>3</sup>However, testosterone levels were more affected by rosiglitazone, liraglutide, beinaglutide, and canagliflozin when used as an additional medication to metformin.</div>

International Journal of Endocrinology

fig2

Figure 2

Figure 2: Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches 

Figure 2 | Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches 